Elevated levels of Lipoprotein(a), a subtype of "bad cholesterol," in bloodstreams are a risk factor for recurrent coronary heart disease (CHD) in persons 60 and older, according to the results of a recent study that studied the issue over a 16-year period.
The results, published today in C
A recent University of Iowa study's findings may aid in the improvement of cognitive impairment in Parkinson's disease (PD) diagnosis as well as the development of novel biomarkers and targeted treatments for the illness's cognitive symptoms.
Fathers can make a significant difference in whether or not an infant is nursed and safely placed to sleep, according to a recent survey of new fathers conducted by the Pregnancy Risk Assessment Monitoring System (PRAMS for Dads).
Researchers have discovered beneficial changes in the immune system that occur naturally during pregnancy. The study was published in 'Journal of Neuroinflammation'.
A study led by Laureate Institute for Brain Research researchers has made significant progress in understanding the mysterious gut-brain connection, a complex relationship that has long baffled scientists due to the difficulty of accessing the body's interior.
Breast cancer medicines known as aromatase inhibitors may diminish the benefit of weight loss therapies, according to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.
According to an industry-supported study at ENDO 2023, the Endocrine Society's annual conference in Chicago, Ill, people with obesity may be less productive at work owing to an increased risk of sickness, which would raise expenditures for companies.
Researchers have discovered a novel type of molecular sensor that allows the malaria parasite to infect human cells or mosquitos at precisely the right time. The study was published in Journal,' Science Advances.'
Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, but adding a second drug squelches the workaround. The study was published in Journal, 'Cell.'
Researchers found a proven and effective osteoporosis medication, which is currently only available as an injection, can now be administered orally via a novel robotic pill.